HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matrix Metalloproteinase-8 is a Novel Pathogenetic Factor in Focal Cerebral Ischemia.

Abstract
The neutrophil collagenase matrix metalloproteinase-8 (MMP8) is a recently identified member of MMPs that have important roles in various inflammation-related disorders. Previously, we identified MMP8 as a new neuroinflammatory mediator in activated microglia by regulating TNF-α productivity. Here, we present evidence that MMP8 is a critical factor for brain damage in transient focal cerebral ischemia by modulating neuroinflammation likely microglial activation and TNF-α production. Biochemical analyses showed upregulation of MMP8 expression at mRNA and protein levels in transient middle cerebral artery occlusion/reperfusion (M/R)-challenged brains. Furthermore, double immunolabeling showed that MMP8 expression was upregulated in the activated microglia of M/R-challenged brains. Assessment of infarct volume, neurological score, and survival/death of neural cells revealed that administration of an MMP8 inhibitor (M8I) immediately after reperfusion reduced brain damage. Histological analyses showed that microglial activation and TNF-α expression in ischemic conditions was abrogated by exposure to M8I, as demonstrated in our previous study using cultured microglia. These outcomes from a pharmacological approach were reaffirmed by a genetic approach using a lentiviral system. Intracerebroventricular microinjection of MMP8-specific shRNA lentivirus reduced the extent of ischemia-induced brain damage, as assessed by infarct volume, neurological score, microglial activation, and TNF-α expression. These results suggest a novel pathogenetic role of MMP8 and implicate modulation of its activity as a tractable strategy for therapies against cerebral ischemia.
AuthorsJeong Eun Han, Eun-Jung Lee, Eunjung Moon, Jong Hoon Ryu, Ji Woong Choi, Hee-Sun Kim
JournalMolecular neurobiology (Mol Neurobiol) Vol. 53 Issue 1 Pg. 231-239 (Jan 2016) ISSN: 1559-1182 [Electronic] United States
PMID25421209 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Claudin-5
  • RNA, Small Interfering
  • Matrix Metalloproteinase 8
Topics
  • Animals
  • Blood-Brain Barrier (drug effects, pathology)
  • Brain (drug effects, enzymology, pathology)
  • Brain Ischemia (complications, enzymology, pathology)
  • Claudin-5 (metabolism)
  • Down-Regulation (drug effects)
  • Infarction, Middle Cerebral Artery (complications, pathology)
  • Inflammation (pathology)
  • Lentivirus (metabolism)
  • Male
  • Matrix Metalloproteinase 8 (metabolism)
  • Mice, Inbred ICR
  • RNA, Small Interfering (metabolism)
  • Reperfusion
  • Up-Regulation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: